Parathyroid Hormone-Related Peptide in Prostate Cancer
Author Information
Author(s): Bryden A A G, Hoyland J A, Freemont A J, Clarke N W, George N J R
Primary Institution: Christie Hospital, University of Manchester, Withington Hospital
Hypothesis
Expression of PTHrP and PTHrP receptor offer an advantage in the genesis of bone metastases in prostate cancer through paracrine and autocrine mechanisms.
Conclusion
The study found high levels of PTHrP and its receptor in both primary prostate cancers and their corresponding bone metastases, suggesting a role in the development of bone metastases.
Supporting Evidence
- PTHrP expression was positive in 13 out of 14 primary tumors and in all 14 metastases.
- Receptor expression was evident in all 14 primaries and 12 out of 14 metastases.
- Co-expression of PTHrP and its receptor was common in both primary tumors and metastases.
Takeaway
This study looked at how a protein called PTHrP is found in both primary prostate cancer and its bone metastases, which might help the cancer spread to bones.
Methodology
Iliac crest bone biopsies were taken from patients with untreated metastatic prostate cancer, and the expression of PTHrP and its receptor was analyzed using in situ hybridization.
Limitations
The sample size is small, and the study does not account for variations in PTHrP expression with tumor grade.
Participant Demographics
Men with untreated adenocarcinoma of the prostate.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website